Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular
disease (CVD), including acute coronary syndrome (ACS), transient ischemic attack (TIA) or …

Objectives The aim of this study was to develop a risk score integrating cytochrome P450
2C19 loss-of-function genotypes with clinical risk factors influencing clopidogrel response …

Background Thromboembolic complications are not uncommon in patients undergoing
neurointerventional procedures. The use of flow diverting stents is associated with higher …

Background The balance between ischemic and bleeding events and their association with
platelet reactivity in patients receiving antiplatelet therapy after percutaneous coronary …

Aims A number of studies have attempted to demonstrate the benefits associated with
personalized antiplatelet therapy guided by platelet function testing, which has led to …

Objectives The aim of this study was to evaluate prospectively the clinical impact of routine
transmission of CYP2C19 genotype in the management of acute ST-segment elevation …

Platelet activation and aggregation have a pivotal role in arterial thrombosis and in the
pathogenesis of both acute coronary syndromes (ACS) and in the thrombotic complications …

Background Glycated albumin (GA) is a marker of short-term glycemic control and is strongly
associated with the occurrence of diabetes. Previous studies have shown an association …

Background The prevalence of ex vivo 'high on-treatment platelet reactivity (HTPR)'and its
relationship with recurrent vascular events/outcomes in patients with ischaemic …

In the field of antithrombotics, precision medicine is of particular interest, as it may lower the
incidence of potentially life-threatening side effects. Indeed, antiplatelet drugs such as …